199 related articles for article (PubMed ID: 27259908)
1. [Declining costs].
Neumaier J
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
[No Abstract] [Full Text] [Related]
2. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
[No Abstract] [Full Text] [Related]
3. Drifting policies are wasting billions.
Suh GH
Int Psychogeriatr; 2012 Mar; 24(3):343-5. PubMed ID: 22078134
[No Abstract] [Full Text] [Related]
4. [The cost of an HIV patient. Lack of funds for optimal treatment?].
Stoll M; Schulte E; Claes C; Graf von der Schulenburg JM; Schmidt RE
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():72-7. PubMed ID: 11373789
[TBL] [Abstract][Full Text] [Related]
5. Access to essential medications for HIV/AIDS in South Africa.
Andrews S
S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
[No Abstract] [Full Text] [Related]
6. Future of medical training in Australia.
Clear PR
Med J Aust; 1998 Aug; 169(4):232. PubMed ID: 9734592
[No Abstract] [Full Text] [Related]
7. [Therapy of hypertension. Cost conscious prevention of complications].
Kolloch RE
MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
[No Abstract] [Full Text] [Related]
8. Closing the affordability gap for drugs in low-income countries.
Steinbrook R
N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957
[No Abstract] [Full Text] [Related]
9. [Unfairly implicated as cost drivers. New drugs without a chance?].
MMW Fortschr Med; 2004 Mar; 146(10):45. PubMed ID: 15347085
[No Abstract] [Full Text] [Related]
10. [Do pharmacists and the state increase drug costs?].
Kaesback W
MMW Fortschr Med; 1999 Dec; 141(48):54. PubMed ID: 10766548
[No Abstract] [Full Text] [Related]
11. [Due to cost considerations too few triptans are prescribed].
Diener HC
MMW Fortschr Med; 2006 Apr; 148(16):63. PubMed ID: 16688955
[No Abstract] [Full Text] [Related]
12. Generic drugs battle moves from South Africa to Kenya.
Siringi S
Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
[No Abstract] [Full Text] [Related]
13. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
14. [Pharmaceutical organization recommends to budget-concerned physicians: simply do without some prescriptions!].
Vorderwulbecke U
MMW Fortschr Med; 1999 Dec; 141(48):56. PubMed ID: 10766549
[No Abstract] [Full Text] [Related]
15. [Not Available].
Wolf E; Rüsenberg R
MMW Fortschr Med; 2015 Jun; 157 Suppl 2():42-5. PubMed ID: 26048120
[No Abstract] [Full Text] [Related]
16. The future of generic HIV drugs in Rhode Island.
Lee JY; Reece R; Montague B; Rana A; Alexander-Scott N; Flanigan T
R I Med J (2013); 2013 Sep; 96(9):30-3. PubMed ID: 24015398
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for generic antiretroviral drugs in the United States?
Wormser GP; Lappas T
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
[TBL] [Abstract][Full Text] [Related]
18. Generic HIV drugs will widen US treatment net.
Maxmen A
Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
[No Abstract] [Full Text] [Related]
19. [Health care too costly? Saving more than 10 million euros in 2 months!].
Rappert B
MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
[No Abstract] [Full Text] [Related]
20. [Public health service in the conflict between cost control and new responsibilities].
Leidel J
Gesundheitswesen; 1996 Nov; 58(11):571-7. PubMed ID: 9081492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
